Compare Oscar Health Inc (OSCR) vs S&P500 ETF (SPY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs S&P500 ETF — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while S&P500 ETF trades at $778.54 (market cap $821.54B). The key difference: S&P500 ETF is far larger — about 80.4× Oscar Health Inc's market cap, and S&P500 ETF is more actively traded (40,070,358 versus 4,123,394). Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and S&P500 ETF for 205 Days on average.
| OSCR | SPY | |
|---|---|---|
Market Cap | $10.22B | $821.54B |
Volume | 4,123,394 | 40,070,358 |
Sector | Health | — |
52-Week High | $33.81 | $779.14 |
52-Week Low | $10.85 | $631.99 |
Typical Hold Time | 15 Days | 205 Days |
Enterprise Value | $6.57B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
SPY, tracking the S&P 500, trades at $773.97, down 0.42% over 24 hours, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The ETF is near its pivot point of $774, with support at $771 and resistance at $777. Recent news highlights mixed sentiment, with some articles pointing to strong profit growth in 2026 but expectations of a slowdown in 2027, while others discuss defensive positioning and valuation concerns amid market volatility.
The outlook for SPY remains tied to broader market dynamics, with potential upside from continued corporate earnings growth but risks from economic slowdowns and elevated valuations. Investors face opportunities from historical year-end rallies cited by analysts, yet must weigh risks like margin debt warnings and profit growth deceleration. Key factors include upcoming economic data and institutional flows influencing near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About S&P500 ETF
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →
